The Pharma industry is considered to be one of the best industries to invest in because it is recession proof and offers stability with long term growth potential. Investing in pharma stocks for a longer horizon can benefit a lot due to constant demand for pharma products.
Here are 3 small cap pharma companies which are fundamentally strong to add in your watchlist:
Marksans Pharma Ltd:
With a market capitalization of 4,984.8 crores, the company is engaged in the Business of Formulation of pharmaceutical products. Their key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology,Antibiotics etc. Company also has a presence in active Pharmaceuticals Ingredients (APIs), formulations and biopharmaceuticals.
The stock of Marksans Pharma Ltd closed at Rs. 111.25 per share, it has delivered multibagger returns of 129.38 percent in the last 1 year. Company’s revenue increased by 24 percent to Rs. 1,852 crores in March 23 from Rs. 1,490.84 crores in March 22, in the same time period net profit increased by 44.29 percent to 266.31 crores from 184.57 crores.
Gujarat Themis Biosyn Ltd
Incorporated in 1981, Gujarat Themis Biosyn Ltd is engaged in the manufacturing and selling finished Active Pharmaceutical Ingredients products by fermentation process. Company manufactures pharmaceuticals and medicinal chemicals. It is actively managed by Themis Medicare. Company has a market capitalization of 1,598.52 crores.
The stock of Gujarat Themis Biosyn Ltd closed at Rs. 219.25 per share, it has delivered 55.12 percent returns in the last 1 year, company’s revenue increased by 30 percent to Rs. 148.97 crores in March 23 from Rs. 148.97 crores in March 22, in the same time period net profit increased by 32.9 percent to 57.97 crores from 43.62 crores. The stock recently underwent a split of 10:1.
Themis Medicare Ltd
The company manufactures and markets bulk APIs of synthetic and biotech origin, bulk intermediates, and formulations. In the formulations segment, the company manufactures anti-TB, anti-malarial, anti-cholesterol, and pain management drugs. The company manufactures 190+ different drugs for 20 different therapeutic areas. Market capitalization of this company is 1575.97 crores.
The stock of Themis Medicare Ltd closed at Rs. 168.55 per share, it has delivered 64.28 percent returns in the last 1 year, company’s revenue decreased by 10.21 percent to Rs. 354.32 crores in March 23 from Rs. 394.61 crores in March 22, in the same time period net profit decreased by 21.93 percent to 56.9 crores from 72.88 crores. This stock also recently underwent a split of 10:1.
Written by: Vinit Israni
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
